Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.8500 (0.88%) ($0.8500 - $0.8500) on Mon. Feb. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.27% (three month average) | RSI | 58 | Latest Price | $0.8500(0.88%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ANPC advances 5.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) INDA(46%) IVE(46%) JETS(45%) XHB(45%) XLB(45%) | Factors Impacting ANPC price | ANPC will decline at least -3.135% in a week (0% probabilities). VIXM(-44%) UNG(-29%) UUP(-28%) GLD(-23%) VXX(-22%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.135% (StdDev 6.27%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.9 | 5 Day Moving Average | $0.86(-1.16%) | 10 Day Moving Average | $0.85(0%) | 20 Day Moving Average | $0.9(-5.56%) | To recent high | -53% | To recent low | 18.1% | Market Cap | $7m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |